Cell Therapeutics (CTIC) Files 12.61M Common Shelf for Shareholders
Tweet Send to a FriendGet Alerts CTIC Hot Sheet
Up)
Trade CTIC Now!
Cell Therapeutics, Inc. (Nasdaq: CTIC) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to 12,605,042 shares of Common Stock on behalf of Selling Shareholders.
Cell Therapeutics will not receive proceeds from the secondary offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Cell Therapeutics will not receive proceeds from the secondary offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI® in 3rd and 4th Line Salvage Setting With and Without Prior Rituximab Treatment
- Home Loan Servicing (HLSS) Commences 12.5M Offering
- Vitesse Semi (VTSS) Announces $30M Common Stock Offering
Create E-mail Alert Related Categories
Equity Offerings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
